Enanta Pharmaceuticals (ENTA) Amortization of Deferred Charges (2013 - 2015)

Enanta Pharmaceuticals has reported Amortization of Deferred Charges for 3 years, with the latest figure at $2000.0 in Q2 2015.

• For the quarter ending Q2 2015, Amortization of Deferred Charges fell 60.0% year-over-year to $2000.0; the trailing twelve-month figure through Mar 2015 stood at $3000.0 (down 87.5% YoY), and the FY2014 full-year result was $8000.0, down 74.19% from the prior year.
• Amortization of Deferred Charges for Q2 2015 stood at $2000.0, roughly flat from $2000.0 in the prior quarter.
• The five-year high for Amortization of Deferred Charges was $8000.0 in Q3 2013, with the low at -$6000.0 in Q3 2014.
• Historically, Amortization of Deferred Charges has averaged $3222.2 across 3 years, with a median of $4000.0 in 2014.
• The largest YoY upside for Amortization of Deferred Charges was 28.57% in 2014 against a maximum downside of 175.0% in 2014.
• Enanta Pharmaceuticals' Amortization of Deferred Charges stood at $5000.0 in 2013, then slumped by 60.0% to $2000.0 in 2014, then changed by 0.0% to $2000.0 in 2015.
• The last three Amortization of Deferred Charges figures came in at $2000.0 (Q2 2015), $2000.0 (Q1 2015), and $2000.0 (Q4 2014), per Business Quant data.